MedTrace Logo

Improved Pain Management in Knee Osteoarthritis-related Surgeries

NCT06124170 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 714

Last updated 2023-11-09

No results posted yet for this study

Summary

In recent years, pain management coordinated with enhanced recovery after surgery (ERAS) has been widely applied and rapidly developed in orthopedics, showing promising prospects. Since 2016, our hospital has used a series of continuously improved pain management schemes for patients with knee OA who underwent total knee arthroplasty (TKA), unicompartmental knee arthroplasty (UKA), and high tibial osteotomy (HTO). Here, we retrospectively analyze these patients' clinical data to compare the effects of different pain intervention measures during the perioperative period on postoperative pain, functional exercise, hospital stay, and prognosis of the three surgical methods in an attempt to provide a feasible solution for pain management of these patients.

Conditions

  • Knee Osteoarthritis
  • Total Knee Arthroplasty
  • Unicompartmental Knee Arthroplasty
  • High Tibial Osteotomy
  • Pain Management

Interventions

PROCEDURE

Preoperative pain managment

propaganda and education on pain; Preemptive analgesia with celecoxib (200 mg bid) 2 days before surgery

PROCEDURE

Intraoperative pain managment

Squeeze to expel blood (tourniquet); Before skin suture, 20 mL 0.5% ropivacaine was given subcutaneously for local infiltration anesthesia;

PROCEDURE

Postoperative pain managment

The intravenous analgesia pump was placed until 48 h after surgery;On the second day after surgery, celecoxib (200 mg bid) was administered orally, and buprenorphine transdermal patch was applied externally until hospital discharge;FNB catheter was placed under the guidance of ultrasound and connected with an analgesic pump, the anesthesia lasted until 48 h after surgery ‡

Sponsors & Collaborators

  • Peng Liu

    lead OTHER

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2022-03-02
Completion
2023-03-02

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06124170 on ClinicalTrials.gov